NPR3

NPR3 Full Name

natriuretic peptide receptor 3

NPR3 Introduction

Researchers studying cardiovascular balance, renal protection, and developmental biology are increasingly focusing on NPR3 (natriuretic peptide receptor 3), also known as NPR-C, because this receptor does far more than simply clear natriuretic peptides from circulation. Unlike NPR1 and NPR2, which stimulate intracellular cGMP production, NPR3 primarily regulates the availability of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and C-type natriuretic peptide (CNP) through receptor-mediated internalization and degradation. This "clearance receptor" function makes NPR3 a critical checkpoint for maintaining vascular tone, sodium balance, cardiac remodeling, and fluid homeostasis. High NPR3 expression has been detected in the heart, kidney, adrenal tissue, vascular smooth muscle, and central nervous system, highlighting its broad physiological relevance. Recent studies have also shown that NPR3 is not merely a passive scavenger receptor; it can actively modulate intracellular signaling by coupling to inhibitory G proteins and suppressing adenylate cyclase activity, thereby influencing cAMP-dependent pathways. For researchers and drug developers, this dual regulatory mechanism positions NPR3 as an increasingly attractive therapeutic target in diseases where natriuretic peptide signaling becomes dysregulated.

Interest in NPR3 has expanded rapidly because developmental and regenerative biology studies revealed that the receptor plays essential roles during embryogenesis and tissue patterning. Emerging evidence demonstrates that NPR3 coordinates the formation of neural crest and cranial placode progenitors through its combined clearance and signaling activities, balancing cGMP and cAMP pathways during early development. These findings help explain how disturbances in natriuretic peptide signaling may contribute to craniofacial abnormalities, sensory organ defects, and altered skeletal formation. In cardiovascular research, NPR3 is now recognized as a key modulator of cardiac growth and vascular remodeling, especially under conditions of hypertension and heart failure where natriuretic peptide pathways are chronically activated. Kidney researchers are similarly investigating NPR3 because local natriuretic peptide signaling within the glomerulus appears essential for preserving renal filtration integrity and podocyte stability. Dysregulated NPR3 activity may therefore contribute to chronic kidney disease progression, glomerular injury, and fluid imbalance disorders that remain difficult to treat effectively with current therapies.

The clinical relevance of NPR3 has further increased with growing evidence linking the receptor to cancer biology and immune-related disease mechanisms. Pan-cancer analyses have shown that NPR3 expression is altered across multiple tumor types, with reduced expression observed in several renal and solid tumors. Importantly, NPR3 levels have been associated with tumor stage, immune infiltration, metastatic potential, and patient prognosis, suggesting that the receptor may serve as both a biomarker and a therapeutic response indicator. Mechanistically, NPR3 appears capable of influencing tumor progression through interactions with MAPK signaling, adenylate cyclase pathways, and the broader renin-angiotensin-aldosterone system (RAAS). Because many cancers exploit metabolic and microenvironmental signaling networks for survival, understanding how NPR3 regulates peptide clearance and intracellular communication may open new opportunities for targeted therapy development. As precision medicine increasingly depends on identifying multifunctional regulatory proteins, NPR3 is emerging as a promising target at the intersection of cardiovascular disease, renal pathology, developmental disorders, and oncology research.

Alternate Names for NPR3

NPR3; natriuretic peptide receptor 3; NPRC; ANP-C; ANPRC; NPR-C; ANPR-C; GUCY2B; C5orf23; atrial natriuretic peptide receptor 3; guanylate cyclase C; atrionatriuretic peptide receptor C; atrial natriuretic peptide receptor type C; atrial natriuretic peptide clearance receptor; natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C);

• 1.Juraver-Geslin H, et al.; Developmental roles of natriuretic peptides and their receptors. Cells Dev. 2023, 176:203878.
  2.Devotta A, et al.; Npr3 regulates neural crest and cranial placode progenitors formation through its dual function as clearance and signaling receptor. Elife. 2023, 12:e84036.